447 results on '"Vaishnaw A"'
Search Results
2. Pharmacological screening of anti-inflammatory and analgesic activity of apigenin in mice model
3. Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases
4. Evaluation of the Hepatoprotective potential and Antioxidant activity of 4–Hydroxybenzyl alcohol on Carbon tetrachloride Induced liver damage in Experimental animals
5. Synthesis and characterization of Ni:ZnO thin films as photoanode for planar perovskite solar cell
6. Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases
7. Investigating the Risk of Airborne COVID-19 and the Importance of Social Restrictions in Regulating the Transmission
8. CovidExplorer: A Multi-faceted AI-based Search and Visualization Engine for COVID-19 Information
9. GC-MS analysis of Ichnocarpus frutescens (L.) W.T. aiton root hydro-alcoholic extract
10. Continuous Evolution for 5G: Comprehensive Study and Challenges
11. A Method of Micro Pixel Similarity for Lung Cancer Diagnosis Using Adaboost
12. Investigating the Risk of Airborne COVID-19 and the Importance of Social Restrictions in Regulating the Transmission
13. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity
14. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma
15. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity
16. Mathematical model on Post-COVID pulmonary fibrosis: A case study on a COVID patient.
17. CovidExplorer: A Multi-faceted AI-based Search and Visualization Engine for COVID-19 Information.
18. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry
19. Exploring the Average Information Parameters over Lung Cancer for Analysis and Diagnosis
20. Evaluation of the Hepatoprotective potential and Antioxidant activity of 4–Hydroxybenzyl alcohol on Carbon tetrachloride Induced liver damage in Experimental animals
21. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry
22. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
23. 4th International Conference on the Role of Innovation, Entrepreneurship, and Management for Sustainable Development (ICRIEMSD-2023)
24. Enhanced Frequency-Based Word Embedding Approach For Text Analysis: Comparative Study With Existing Method
25. An Innovative Approach for Investigation and Diagnosis of Lung Cancer by Utilizing Average Information Parameters
26. Neurofilament light chain (NfL) as a biomarker of hereditary transthyretin-mediated amyloidosis
27. GC-MS Analysis of Ichnocarpus frutescens (L.) W.T. Aiton Root Hydro-Alcoholic Extract
28. Oil extraction, biochemical activities and in silico analysis for active compound valorization in Azardiricta indica seeds and production of microbial oil using Saccharomyces cerevisiae
29. Reverse Dictionary Using an Improved CBoW Model.
30. Review Based Recommendations with Human-like Reasons.
31. Nutritional Status of School Age Children in Urban Slum Area in Vijayawada and Guntur
32. Abstract 14387: Dose-Related Reductions in Blood Pressure With a RNA Interference (RNAi) Therapeutic Targeting Angiotensinogen in Hypertensive Patients: Interim Results From a First-In-Human Phase 1 Study of ALN-AGT01
33. Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
34. Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
35. Data from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
36. Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
37. Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
38. Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
39. Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
40. Molecular genetics of the complement protein C4
41. Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults
42. Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy
43. Exploring the Average Information Parameters over Lung Cancer for Analysis and Diagnosis
44. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study
45. GC-MS Analysis of Ichnocarpus frutescens (L.) W.T. Aiton Root Hydro-Alcoholic Extract
46. Continuous Evolution for 5G: Comprehensive Study and Challenges
47. Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
48. Preclinical and Clinical Studies Employing RNA Interference as a Therapeutic for Respiratory Syncytial Virus (RSV) Infection in the Lung
49. Investigating the Risk of Airborne COVID-19 and the Importance of Social Restrictions in Regulating the Transmission
50. Computational Simulation of the Effect of Increase in the Estrogen level on the Normal- Tumour- Immune- Unhealthy Diet Model for breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.